Between 2013 and 2023, China's Hormones in Dosage Except Contraceptives and Antibiotics Market demonstrated robust growth, reaching 8.0178 billion USD in 2023. The market experienced substantial increases, particularly in 2017 and 2021, although faced a minor decline in 2022. Over the past five years, it maintained a moderate CAGR of 4.28%, despite fluctuations over the years.

Future trends to watch for include:

Potential growth in demand driven by advancements in healthcare technologies and an aging population.
Evolving regulatory landscapes could influence market dynamics.
Continued development of new hormone therapies and expansion in the treatment of various conditions to steer market growth.